(Q46728767)

24 December 2017

meta-analysis

0 references

title

Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies (English)

1 reference

24 December 2017

main subject

Staphylococcus aureus

1 reference

1 reference

1 reference

3

Marin Kollef

1 reference

24 December 2017

Andrew F Shorr

1

1 reference

24 December 2017

Mark J Kunkel

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

29 September 2005

1 reference

24 December 2017

Journal of Antimicrobial Chemotherapy

published in

1 reference

24 December 2017

volume

56

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

page(s)

923-929

1 reference

24 December 2017

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Monitoring serum vancomycin levels: climbing the mountain because it is there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI355

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI355

1 reference

24 December 2017

release_ohhao6tfgrgu7m6s3e2e5rxoji

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ohhao6tfgrgu7m6s3e2e5rxoji

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

24 December 2017